REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $705,000 | -85.7% | 810,646 | -58.4% | 0.02% | -82.2% |
| Q1 2022 | $4,914,000 | -1.6% | 1,950,002 | +0.7% | 0.11% | +5.9% |
| Q4 2021 | $4,994,000 | -44.8% | 1,935,589 | -2.1% | 0.10% | -43.6% |
| Q3 2021 | $9,052,000 | -33.4% | 1,976,476 | 0.0% | 0.18% | -31.2% |
| Q2 2021 | $13,598,000 | +1.6% | 1,976,476 | +8.1% | 0.26% | -4.1% |
| Q1 2021 | $13,385,000 | -18.4% | 1,828,587 | -9.9% | 0.27% | -14.2% |
| Q4 2020 | $16,396,000 | -24.0% | 2,029,195 | -3.9% | 0.32% | -37.4% |
| Q3 2020 | $21,579,000 | +52.1% | 2,111,451 | -0.3% | 0.50% | +46.8% |
| Q2 2020 | $14,189,000 | +83.8% | 2,117,817 | +24.2% | 0.34% | +95.5% |
| Q1 2020 | $7,721,000 | -31.3% | 1,704,489 | -8.0% | 0.18% | -4.9% |
| Q4 2019 | $11,244,000 | +39.5% | 1,852,362 | +61.8% | 0.18% | +24.2% |
| Q3 2019 | $8,061,000 | +8.7% | 1,145,014 | +0.4% | 0.15% | +8.0% |
| Q2 2019 | $7,413,000 | -22.4% | 1,140,464 | -0.8% | 0.14% | -17.9% |
| Q1 2019 | $9,556,000 | +50.6% | 1,149,935 | +0.6% | 0.17% | +28.2% |
| Q4 2018 | $6,344,000 | +2050.5% | 1,143,001 | +3318.7% | 0.13% | +2520.0% |
| Q3 2018 | $295,000 | – | 33,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |